Quick answer: In Pune, as of June 2026, Mounjaro costs ₹13,125–₹25,781 per month at MRP, generic semaglutide starts near ₹1,290 per month, and endocrinologist consults run ₹1,000–₹1,400 at hospitals like Ruby Hall, Jupiter and Chellaram — no Mumbai trip required. A realistic six months of supervised treatment in Pune runs from roughly ₹25,000 on generics to ₹1.1 lakh+ on branded tirzepatide. GLP-1s are prescription-only; online video prescriptions from registered doctors are legal across Maharashtra.

First, kill the Mumbai myth

A surprising number of Punekars still assume serious metabolic care means an expressway trip to Mumbai. It doesn't — and on this specific condition, Pune is arguably better equipped per rupee. The city has something rare: Chellaram Hospital in Bavdhan, a dedicated diabetes and multispecialty hospital — an institution literally built around the metabolic conditions GLP-1s treat — alongside deep endocrinology benches at Ruby Hall (Dhole Patil Road & Wanowrie), Jehangir, Deenanath Mangeshkar, Sahyadri, Jupiter (Baner), Apollo, and Aditya Birla Memorial in Pimpri-Chinchwad. Consults here cost roughly half of Mumbai's. The medicine costs exactly the same — MRPs are national.

The 6-month budget, Pune edition

GLP-1 treatment is a months-long protocol, so single-month sticker prices mislead. Here's the honest six-month arithmetic for a typical titration (start low, step up ~every 4 weeks as tolerated), using June 2026 MRPs:

Path Medicine (6 mo, typical titration) Supervision (in-person route: 1 initial + 5 follow-ups @ ₹1,000–1,400) Baseline labs 6-month total
Generic semaglutide vials (e.g., Semanat)~₹8,000–15,000₹6,000–8,400₹1,800–3,000~₹16,000–26,000
Generic semaglutide pens (e.g., Semasize, Semaglyn)~₹12,000–20,000₹6,000–8,400₹1,800–3,000~₹20,000–31,000
Wegovy (branded, post April-2026 cut)~₹45,000–60,000₹6,000–8,400₹1,800–3,000~₹53,000–71,000
Mounjaro (tirzepatide)~₹90,000–1,05,000₹6,000–8,400₹1,800–3,000~₹98,000–1,16,000

(Medicine ranges assume 2–3 months at starter doses before stepping up; your doctor's titration sets the real number. Tirzepatide and semaglutide are different molecules — the price gap buys the drug with the higher trial-average weight loss, not just a brand.) Run this math at your dose with the cost calculator.

The consult line uses real Pune fees from current Practo listings (June 2026):

Where Area Consult fee
Chellaram Hospital (diabetes specialty)Bavdhan₹1,400
Apollo HospitalsShankar Shet Road₹1,450
Ruby Hall ClinicDhole Patil Road / Wanowrie₹1,200–1,300
Jupiter HospitalBaner₹1,000–1,300
Aditya Birla MemorialPimpri-Chinchwad₹1,000
Standalone endocrine clinicsKothrud, Swargate, Kharadi, Wakad, Akurdi₹650–1,500

Practo's own Pune aggregate puts routine diabetes consultations at ₹400–₹1,200 — the value end of India's metros, with the PCMC belt cheapest.

Start in Pune without the Hinjewadi commute

Video consult with a registered physician, labs collected at home across Pune and PCMC, e-prescription valid at any licensed pharmacy — titration follow-ups included.

Where Pune buys

  1. Wellness Forever. Strong Pune presence (Deccan, Aundh, Baner, Viman Nagar, Kothrud and beyond); dependable for cold-chain branded pens against prescription.
  2. MedPlus, Apollo Pharmacy, Noble. Coverage across the city and PCMC; hospital-adjacent outlets (near Ruby Hall, Jehangir, DMH) restock branded and generic GLP-1s fastest.
  3. Hospital pharmacies. Ruby Hall, Chellaram, Jupiter, Sahyadri, DMH and Aditya Birla counters dispense against outside prescriptions.
  4. Online cold-chain delivery. Tata 1mg, PharmEasy and Apollo 24/7 serve both Pune and Pimpri-Chinchwad with ice-pack packaging; prescription upload mandatory. New generic semaglutide brands (Semanat, GLIPIQ, Semasize, Semaglyn, Obeda — 40+ DCGI-approved since the 20 March 2026 patent expiry) reached Pune's chain outlets within weeks; smaller chemists in the peths may need a day to order.
  5. Avoid anyone selling without a prescription — illegal, and the channel where counterfeit pens have circulated in India. With legal generics from ₹1,290/month, the grey market has no remaining argument.

Pune's two-city problem, and the online answer

Pune is really two cities welded together. Specialists concentrate in the old core and the Deccan–Koregaon Park arc; the GLP-1 demographic concentrates in Hinjewadi, Wakad, Baner, Kharadi, Magarpatta and the PCMC industrial belt. A Hinjewadi-to-Dhole-Patil-Road follow-up through Pune traffic is a 3-hour round trip for a 10-minute titration review — twelve times a year on the standard protocol.

Telemedicine collapses that map. Under India's Telemedicine Practice Guidelines (2020), a registered medical practitioner can evaluate you by video and issue a prescription valid at any licensed pharmacy — the Wellness Forever in Baner or the chemist outside Ruby Hall, your pick. For Pune's students and early-career professionals (the city's other huge cohort, and a budget-sensitive one), online supervision plus generic semaglutide is the first genuinely affordable, genuinely medical route this category has had: roughly the cost of a gym membership, with a doctor attached.

How Kaivo works if you're in Pune

Kaivo is an online, doctor-led GLP-1 program: video consultation with a registered physician, baseline blood panel with home sample collection across Pune and PCMC, and an e-prescription you fill wherever you choose — Kaivo sells no medication and takes no markup, so the generic-versus-branded decision is made on your clinical picture and the 6-month math above, not a platform's inventory. Then 4-weekly titration reviews without the Hinjewadi commute, between-visit side-effect support, plateau troubleshooting, and a maintenance plan from day one — because the trial data is blunt about what happens without structure: in STEP-1's extension, people who stopped semaglutide without support regained about two-thirds of lost weight within a year. Supervised benchmarks worth aiming at: ~15% average loss at 68 weeks on semaglutide 2.4 mg (STEP-1); up to ~20.9% at 72 weeks on tirzepatide (SURMOUNT-1).

Reading from another city? See our guides for Bangalore, Hyderabad, Mumbai and Delhi-NCR.

Sources

  1. Eli Lilly India — Mounjaro (tirzepatide) KwikPen MRPs by dose (₹13,125 / ₹16,406 / ₹20,625 / ₹25,781 per month), corroborated by May 2026 price trackers; no price cut announced as of June 2026.
  2. Reuters — Novo Nordisk India price reductions of up to 48% (Wegovy) and 36% (Ozempic) effective 1 April 2026; Wegovy 0.25 mg at ₹5,660/month.
  3. CNBC-TV18 / Business Today — post-patent generic semaglutide launches from 20 March 2026: 40+ DCGI-approved brands; Natco Semanat ~₹1,290/month, Alkem Semasize from ~₹1,800, Zydus Semaglyn ~₹2,200; Dr. Reddy's Obeda oral tablets (₹99/₹135/₹225), 20 May 2026.
  4. Practo — Pune endocrinologist and clinic consultation fee listings, pulled June 2026 (city aggregate for diabetes consultations ₹400–₹1,200); re-verified quarterly.
  5. Telemedicine Practice Guidelines, Board of Governors (MCI) / Ministry of Health & Family Welfare, 25 March 2020.
  6. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). NEJM 2021.
  7. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of subcutaneous semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism 2022.
  8. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022.
This article is for education and does not replace medical advice, diagnosis or treatment. GLP-1 medicines are prescription drugs (Schedule H) in India; eligibility is determined only by a registered medical practitioner. The six-month totals are estimates composed from the cited components under a typical titration — your dose schedule sets the real number; never treat them as quotes. Mounjaro® is a registered trademark of Eli Lilly and Company; Wegovy® and Ozempic® of Novo Nordisk; generic brand names belong to their respective makers. Hospital, clinic and pharmacy names appear solely as neutral statements of availability and pricing — Kaivo is not affiliated with, and does not imply endorsement by, any of them. Medically reviewed by Dr. Rinku Sarmah, MBBS, MD (Internal Medicine), AIIMS-trained — Clinical Lead, Kaivo. Last updated 10 June 2026.